Oragenics Inc Share Price Nyse
Equities
US6840232036
Biotechnology & Medical Research
Sales 2022 | 0.13 10.94 | Sales 2023 | 0.04 3.13 | Capitalization | 14.46M 1.2B |
---|---|---|---|---|---|
Net income 2022 | -14M -1.16B | Net income 2023 | -20M -1.66B | EV / Sales 2022 | 1,18,42,208 x |
Net cash position 2022 | 10.8M 899M | Net cash position 2023 | 3.16M 263M | EV / Sales 2023 | 29,99,79,895 x |
P/E ratio 2022 |
-0.89
x | P/E ratio 2023 |
-0.61
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 76.77% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Redmond
CEO | Chief Executive Officer | 64 | 28/12 |
Janet Huffman
DFI | Director of Finance/CFO | 52 | 07/23/07 |
Kimberly Murphy
BRD | Director/Board Member | 62 | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Pope
CHM | Chairman | 73 | 04/10/04 |
John Gandolfo
BRD | Director/Board Member | 63 | 04/23/04 |
Robert Koski
BRD | Director/Board Member | 65 | 30/09/30 |
1st Jan change | Capi. | |
---|---|---|
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |